Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Mol Ther ; 31(7): 2169-2187, 2023 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-37211762

RESUMEN

Hypertrophic lysosomes are critical for tumor progression and drug resistance; however, effective and specific lysosome-targeting compounds for cancer therapy are lacking. Here we conducted a lysosomotropic pharmacophore-based in silico screen in a natural product library (2,212 compounds), and identified polyphyllin D (PD) as a novel lysosome-targeted compound. PD treatment was found to cause lysosomal damage, as evidenced by the blockade of autophagic flux, loss of lysophagy, and the release of lysosomal contents, thus exhibiting anticancer effects on hepatocellular carcinoma (HCC) cell both in vitro and in vivo. Closer mechanistic examination revealed that PD suppressed the activity of acid sphingomyelinase (SMPD1), a lysosomal phosphodieserase that catalyzes the hydrolysis of sphingomyelin to produce ceramide and phosphocholine, by directly occupying its surface groove, with Trp148 in SMPD1 acting as a major binding residue; this suppression of SMPD1 activity irreversibly triggers lysosomal injury and initiates lysosome-dependent cell death. Furthermore, PD-enhanced lysosomal membrane permeabilization to release sorafenib, augmenting the anticancer effect of sorafenib both in vivo and in vitro. Overall, our study suggests that PD can potentially be further developed as a novel autophagy inhibitor, and a combination of PD with classical chemotherapeutic anticancer drugs could represent a novel therapeutic strategy for HCC intervention.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Humanos , Carcinoma Hepatocelular/patología , Sorafenib/farmacología , Esfingomielina Fosfodiesterasa/farmacología , Neoplasias Hepáticas/metabolismo , Lisosomas/metabolismo , Autofagia , Resistencia a Medicamentos , Punciones
2.
Cancer Lett ; 590: 216826, 2024 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-38574881

RESUMEN

Ferroptosis, an iron-dependent regulated cell death caused by excessive lipid peroxide accumulation, has emerged as a promising therapeutic target in various cancers, including non-small cell lung cancer (NSCLC). In this study, we identified the long non-coding RNA RGMB-AS1 as a key regulator of ferroptosis in NSCLC. Mechanistically, RGMB-AS1 interacted with heme oxygenase 1 (HMOX1) and prevented its ubiquitination by the E3 ligase TRC8, leading to increased HMOX1 stability and enhanced ferroptosis. Additionally, RGMB-AS1 bound to the 82-87 amino acid region of N-alpha-acetyltransferase 10 (NAA10), stimulating its acetyltransferase activity and promoting the conversion of acetyl-CoA to HMG-CoA, further contributing to ferroptosis. The RGMB-AS1-HMOX1 and RGMB-AS1-NAA10 axes synergistically inhibited NSCLC growth both in vitro and in vivo. Clinically, low RGMB-AS1 expression was associated with advanced tumor stage and poor overall survival in NSCLC patients. Furthermore, adeno-associated virus-mediated RGMB-AS1 overexpression significantly suppressed tumor growth in mouse xenograft models. Our findings uncover a novel lncRNA-mediated regulatory mechanism of ferroptosis and highlight the potential of RGMB-AS1 as a prognostic biomarker and therapeutic target in NSCLC.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas , Ferroptosis , Hemo-Oxigenasa 1 , Neoplasias Pulmonares , ARN Largo no Codificante , Ubiquitinación , Ferroptosis/genética , Humanos , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/patología , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/metabolismo , Animales , Hemo-Oxigenasa 1/genética , Hemo-Oxigenasa 1/metabolismo , Ratones , Línea Celular Tumoral , Regulación Neoplásica de la Expresión Génica , Femenino , Masculino , Ratones Desnudos , Células A549 , Ensayos Antitumor por Modelo de Xenoinjerto , Proliferación Celular
3.
J Adv Res ; 51: 135-147, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-36396045

RESUMEN

INTRODUCTION: Acquired resistance to BRAF inhibitor vemurafenib is frequently observed in metastatic colorectal cancer (CRC), and it is a thorny issue that results in treatment failure. As adaptive responses for vemurafenib treatment, a series of cellular bypasses are response for the adaptive feedback reactivation of ERK signaling, which warrant further investigation. OBJECTIVES: We identified ARF1 (ADP-ribosylation factor 1) as a novel regulator of both vemurafenib resistance and cancer metastasis, its molecular mechanism and potential inhibitor were investigated in this study. METHODS: DIA-based quantitative proteomics and RNA-seq were performed to systematic analyze the profiling of vemurafenib-resistant RKO cells (RKO-VR) and highly invasive RKO cells (RKO-I8), respectively. Co­immunoprecipitation assay was performed to detect the interaction of ARF1 and IQGAP1 (IQ-domain GTPase activating protein 1). An ELISA-based drug screen system on FDA-approved drug library was established to screen the compounds against the interaction of ARF1-IQGAP1.The biological functions of ARF1 and LY2835219 were determined by transwell, western blotting, Annexin V-FITC/PI staining and in vivo experimental metastasis assays. RESULTS: We found that ARF1 strongly interacted with IQGAP1 to activate ERK signaling in VR and I8 CRC cells. Deletion of IQGAP1 or inactivation of ARF1 (ARF-T48S) restored the invasive ability induced by ARF1. As ARF1-IQGAP1 interaction is essential for ERK activation, we screened LY2835219 as novel inhibitor of ARF1-IQGAP1 interaction, which inactivated ERK signaling and suppressed CRC metastasis and vemurafenib-resistance in vitro and in vivo with no observed side effect. Furthermore, LY2835219 in combined treatment with vemurafenib exerted significantly inhibitory effect on ARF1-mediated cancer metastasis than used independently. CONCLUSION: This study uncovers that ARF1-IQGAP1 interaction-mediated ERK signaling reactivation is critical for vemurafenib resistance and cancer metastasis, and that LY2835219 is a promising therapeutic agent for CRC both as a single agent and in combination with vemurafenib.


Asunto(s)
Factor 1 de Ribosilacion-ADP , Neoplasias Colorrectales , Humanos , Vemurafenib/farmacología , Vemurafenib/uso terapéutico , Línea Celular Tumoral , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/patología
4.
Biomaterials ; 284: 121481, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35405576

RESUMEN

Generation of a promising antioxidative reagent with superior biocompatibility is urgently needed to remedy spinal cord injuries (SCI), repair the damaged neurons and restrain the secondary injuries caused by inflammation-induced oxidative stress. Inhibitory elements in the injury sites and necessitous inherent neural regeneration ability were major challenges for functional recovery after spinal cord injuries. We here developed a highly bioactive iridium complex (IrFPHtz) with enhanced antioxidative activities and improved SCI therapeutic efficacy. Both in vivo and in vitro, IrFPHtz has exhibited neuroprotective and anti-inflammatory properties. Mechanically, IrFPHtz directly targets SOD1 and upregulates the expression of SOD1 to eliminate the excess Reactive Oxygen Species (ROS) production induced by SCI, and thus protecting neuron cells from further damage. As a result, IrFPHtz safeguarded the neurons and myelin sheaths against trauma, lessened glial scar conformations and facilitated the repair of neurons and long axon expansion in the glial scar. Furthermore, IrFPHtz significantly ameliorated the behavioral functions of SCI mice and promoted a satisfactory curative effect. Therefore, this study sheds light on a novel method for SCI treatment using IrFPHtz as a potential drug and implicates the clinical significance of metal complexes in diseases featuring with upregulated ROS species.


Asunto(s)
Complejos de Coordinación , Traumatismos de la Médula Espinal , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Complejos de Coordinación/farmacología , Gliosis , Inflamación/tratamiento farmacológico , Iridio , Ratones , Especies Reactivas de Oxígeno/metabolismo , Médula Espinal , Traumatismos de la Médula Espinal/terapia , Superóxido Dismutasa-1/farmacología , Superóxido Dismutasa-1/uso terapéutico
5.
Mol Biomed ; 2(1): 22, 2021 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-35006426

RESUMEN

Post-translational modifications (PTMs) of Cyclin-dependent kinase 5 (CDK5) have emerged as important regulatory mechanisms that modulate cancer development in patients. Though CDK5 is an atypical member of the cyclin-dependent kinase family, its aberrant expression links to cell proliferation, DNA damage response, apoptosis, migration and angiogenesis in cancer. Current studies suggested that, new PTMs on CDK5, including S-nitrosylation, sumoylation, and acetylation, serve as molecular switches to control the kinase activity of CDK5 in the cell. However, a majority of these modifications and their biological significance in cancer remain uncharacterized. In this review, we discussed the role of PTMs on CDK5-mediated signaling cascade, and their possible mechanisms of action in malignant tumors, as well as the challenges and future perspectives in this field. On the basis of the newly identified regulatory signaling pathways of CDK5 related to PTMs, researchers have investigated the cancer therapeutic potential of chemical compounds, small-molecule inhibitors, and competitive peptides by targeting CDK5 and its PTMs. Results of these preclinical studies demonstrated that targeting PTMs of CDK5 yields promising antitumor effects and that clinical translation of these therapeutic strategies is warranted.

6.
Am J Cancer Res ; 11(7): 3575-3593, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34354861

RESUMEN

Human hepatocellular carcinoma (HCC) is the most frequent cancer worldwide with a poor prognosis. Tumor-specific pyruvate kinase M2 (PKM2) is essential for cancer metabolism and tumorigenesis. Shikonin, a specific inhibitor of PKM2, but not PKM1, exhibits significant anticancer effect in HCC, and was deemed as a promising drug for cancer therapy. However, shikonin-mediated bypass signaling in HCC remained unclear. Here, we performed forward/reverse stable isotope labeling with amino acids in cell culture (SILAC)-based proteomics to identify the early molecular events controlled by shikonin. We demonstrated for the first time that shikonin could induce the nuclear translocation of PKM2 for recruiting Nrf2, and transcriptionally activated Nrf2 downstream target gene BAG3, therefore increasing protective effect to sustain cell survival. Knockdown of BAG3 by si-RNA significantly potentiated the anticancer effect of shikonin. These findings provided the first evidence of a new noncanonical function of inhibited PKM2 could act as a transcriptional coactivator of Nrf2 in cancer survival, highlight that shikonin in combined with BAG3 inhibitor could be a promising therapeutic strategy for HCC therapy.

7.
Zhonghua Yu Fang Yi Xue Za Zhi ; 42(8): 569-73, 2008 Aug.
Artículo en Zh | MEDLINE | ID: mdl-19115619

RESUMEN

OBJECTIVE: To evaluate the effect of snail control through soil pasting mixed with niclosamide. METHODS: Four sites were selected in different epidemic areas in Sichuan province. Soil pasting mixed with niclosamide was carried on, and the dosage was 0 g/m2, 4 g/m2, 6 g/m2, 8 g/m2 and 10 g/m2 respectively. The mortality rate of snail and the density of snail were observed after 7, 15, 30, 90 and 180 days. RESULTS: The mortality rate of snail was more than 43.3% in blank group after 30 days. The mortality rate of snail was from 75.3% to 100.0% at 4 g/m2 group after 30 days. The mortality rate of snail in 4 g/m2 group was significantly higher than that in the blank group (chi2 = 31.27, P < 0.05). There was no significant difference in the mortality rate of snail among all study groups (chi2 = 1.07, P > 0.05). The decrease rate of snail density was more than 90%. The mortality rate of snail was about 30% higher in Chantu group than Qutu group. The unit cost of Pasting-Mixing Drug with Soil was from 5 to 7 times of spray method, but the total cost was similar for the. two methods at the endpoint of the snail control. CONCLUSION: The effect of soil pasting mixed with niclosamide is good, and the dosage of 4-6 g/m2 is suggested in snail control.


Asunto(s)
Moluscocidas , Niclosamida , Control de Plagas , Esquistosomiasis/prevención & control , Caracoles , Animales , Esquistosomiasis/epidemiología , Suelo
8.
Ying Yong Sheng Tai Xue Bao ; 29(4): 1147-1155, 2018 Apr.
Artículo en Zh | MEDLINE | ID: mdl-29726223

RESUMEN

We analyzed the dynamics of stand growth and soil nutrient availability during the degradation processes of Phyllostachys praecox plantation, taking the advantage of bamboo forest stands with different mulching ages (0, 3, 6, 9 and 12 a). The results showed the aboveground and belowground biomass of bamboo forest reached the maximum value when they were covered by three years, which was significantly increased by 14.6% and 146.6% compared with the control. The soil nutrient content was affected by the mulching age and soil layer. Soil nutrients gradually accumulated in upper layer. Soil organic carbon and total nitrogen content were increased with the increases of coverage years. The soil total phosphorus content at different soil layers showed a trend of decreasing first and then increasing. It was the lowest level in the surface layer (0-20 cm) and the bottom (40-60 cm) in 6 years, and the subsurface (20-40 cm) soil reached the lowest level in three years. The total potassium content kept increasing in 0-20 cm soil layer, but decreased during the first three years of mulching and then increased in 20-60 cm soil layer. The comprehensive index of soil fertility quality was greatly improved after nine years mulching, with fertility of subsurface soil being better than that of surface and bottom soils. There was no relationship between the soil fertility index and biomass of different organs in bamboo in the different mulching ages. In the subsurface, however, nitrogen content was negatively related to leaf biomass and potassium was negatively correlated with the biomass of leaves and whip roots. Our results indicated that excessive accumulation of soil nutrients seriously inhibited the propagation and biomass accumulation of P. praecox after long-term mulching management and a large amount of fertilizer, which further aggravated the degradation of bamboo plantation.


Asunto(s)
Poaceae , Suelo/química , Biomasa , Fertilizantes , Bosques , Nitrógeno , Fósforo , Raíces de Plantas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA